» Articles » PMID: 34012933

Resistance Exercise Improves Short-term Memory Through Inactivation of NF-κB Pathway in Mice with Parkinson Disease

Overview
Journal J Exerc Rehabil
Date 2021 May 20
PMID 34012933
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Dysfunctions of Parkinson disease (PD) are classified into motor dysfunction, autonomic nervous system dysfunction, and nonmotor dysfunction, and clinical symptoms such as muscle stiffness, tremors, speech disorders, balance disorders, and slow movements appear. Resistance exercise is a main compartment of exercise programs for PD patient. The effect of resistant exercise on short-term memory in PD mice was studied in relation to the activation of nuclear factor (NF)-κB pathway. PD was induced by subcutaneous injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. For resistance exercise, mice performed ladder climbing 5 days per week for 5 weeks. Step-down avoidance test for short-term memory, enzyme-linked immunoassay for tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β, Western bot for NF-κB, NF-κB inhibitor (IκB)-α, B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax), and Bcl-2, and immunohistochemistry for cleaved caspase-3 were done. Latency time was shortened, TNF-α, IL-6, and IL-1β concentration was increased, NF-κB expression and IκB-α phosphorylation were increased, cleaved caspase-3 and Bax expression was enhanced, and Bcl-2 expression was suppressed by PD induction. Latency time was lengthened, TNF-α, IL-6, and IL-1β concentration was decreased, NF-κB expression and IκB-α phosphorylation were suppressed, cleaved caspase-3 and Bax expression was decreased, and Bcl-2 expression was increased in PD mice by resistance exercise or levodopa treatment. Resistance exercise improved short-term memory by inhibiting secretion of proinflammatory cytokines and apoptosis through inactivation of NF-κB. These effects of resistance exercise were similar to levodopa treatment.

Citing Articles

Exercise may improve lung immunity after surgical stress: Evidence from a nephrectomy model via a bioinformatic analysis.

Wu M, Luo H, Chang Y, Yu C, Sung W PLoS One. 2024; 19(6):e0303334.

PMID: 38848417 PMC: 11161109. DOI: 10.1371/journal.pone.0303334.


Polydeoxyribonucleotide ameliorates alcoholic liver injury though suppressing phosphatidylinositol 3-kinase/protein kinase B signaling pathway in mice.

Cho Y, Ko I, Jin J, Hwang L, Kim S, Jeon J J Exerc Rehabil. 2023; 18(6):350-355.

PMID: 36684531 PMC: 9816614. DOI: 10.12965/jer.2244504.252.


Impact of cancer cachexia on respiratory muscle function and the therapeutic potential of exercise.

Murphy B, Mackrill J, OHalloran K J Physiol. 2022; 600(23):4979-5004.

PMID: 36251564 PMC: 10091733. DOI: 10.1113/JP283569.


Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's disease.

Santoro M, Fadda P, Klephan K, Hull C, Teismann P, Platt B J Neurochem. 2022; 164(2):121-142.

PMID: 36184945 PMC: 10098710. DOI: 10.1111/jnc.15699.


Complicated Role of Exercise in Modulating Memory: A Discussion of the Mechanisms Involved.

Ebrahimnejad M, Azizi P, Alipour V, Zarrindast M, Vaseghi S Neurochem Res. 2022; 47(6):1477-1490.

PMID: 35195832 DOI: 10.1007/s11064-022-03552-w.


References
1.
Subedi L, Lee J, Yumnam S, Ji E, Kim S . Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-κB Inhibition and Nrf2/HO-1 Activation. Cells. 2019; 8(2). PMC: 6406309. DOI: 10.3390/cells8020194. View

2.
Ko Y, Ko I . Voluntary Wheel Running Improves Spatial Learning Memory by Suppressing Inflammation and Apoptosis via Inactivation of Nuclear Factor Kappa B in Brain Inflammation Rats. Int Neurourol J. 2020; 24(Suppl 2):96-103. PMC: 7731883. DOI: 10.5213/inj.2040432.216. View

3.
Kelly N, Ford M, Standaert D, Watts R, Bickel C, Moellering D . Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease. J Appl Physiol (1985). 2014; 116(5):582-92. PMC: 4073951. DOI: 10.1152/japplphysiol.01277.2013. View

4.
Dezsi L, Vecsei L . Monoamine Oxidase B Inhibitors in Parkinson's Disease. CNS Neurol Disord Drug Targets. 2017; 16(4):425-439. DOI: 10.2174/1871527316666170124165222. View

5.
Wu X, Liu C, Chen L, Du Y, Hu M, Reed M . Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice. Int Immunopharmacol. 2019; 72:166-175. DOI: 10.1016/j.intimp.2019.03.065. View